Aspirin for primary prevention of cardiovascular disease (revisited).
出版信息
Med Lett Drugs Ther. 2006 Jul 3;48(1238):53.
PMID:16841021
Abstract
摘要
相似文献
1
Aspirin for primary prevention of cardiovascular disease (revisited).
Med Lett Drugs Ther. 2006 Jul 3;48(1238):53.
2
Aspirin for primary prevention of cardiovascular disease?
Drug Ther Bull. 2009 Nov;47(11):122-5. doi: 10.1136/dtb.2009.10.0045.
3
[Primary prevention of cardiovascular disease].
Dtsch Med Wochenschr. 2005 Jan 7;130(1-2):38-43. doi: 10.1055/s-2005-837373.
4
[Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Dtsch Med Wochenschr. 2005 Dec 9;130(49):2847-52. doi: 10.1055/s-2005-923318.
5
[The role of aspirin in the primary prevention of cardiovascular disease].
Rev Med Suisse. 2006 Mar 8;2(56):646-51.
6
Aspirin for all over 50 revisited.
Heart. 2008 Nov;94(11):1364-5. doi: 10.1136/hrt.2008.155887. Epub 2008 Sep 2.
7
Platelet inhibitors: what are the data in women?
Cardiol Rev. 2008 Jan-Feb;16(1):23-9. doi: 10.1097/CRD.0b013e31815a7e30.
8
Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
Am J Cardiol. 2006 Sep 15;98(6):746-50. doi: 10.1016/j.amjcard.2006.04.012. Epub 2006 Jul 26.
9
[Aspirin and primary prevention of cardiovascular diseases in the elderly].
Rev Esp Geriatr Gerontol. 2009 Nov-Dec;44(6):349-51. doi: 10.1016/j.regg.2009.06.001. Epub 2009 Sep 1.
10
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
J Vasc Nurs. 2010 Dec;28(4):154-5. doi: 10.1016/j.jvn.2010.10.002.
Zotero 插件